BRIEF COGNITIVE and DELIRIUM ASSESSMENTS in STROKE PATIENTS (NCT06670716) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
BRIEF COGNITIVE and DELIRIUM ASSESSMENTS in STROKE PATIENTS
Czechia60 participantsStarted 2024-04-03
Plain-language summary
The aim of the project is to validate the ALBA and PICNIR tests for the easy detection of memory and speech disorders in patients after a stroke. Patients, after their first stroke, with the possibility of initial clinical evaluation within 24 hours of admission to the Neurology Clinic ICU, will undergo a neurological examination, cognitive tests using the ALBA and PICNIR tests, delirium tests using the CAM-ICU and ICDSC tools, and a speech therapy test using the MASTcz tool. If possible, these will be conducted simultaneously in one half-day. A similar structured examination will take place within five days, with a tolerance of one day. Upon demonstrating utility, doctors will be able to utilize the very brief ALBA and POBAV methods for detecting memory and speech disorders in post-stroke patients in clinical practice.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Native speaker of the Czech Republic. Czech must be the patient\'s native language.
* Admission to the monitored bed of the neurological ICU with the possibility of initial examination within 24 hours of admission (not the onset of CVA).
* Anticipated length of hospitalization longer than five days.
* First clinical CVA in life. Subclinical signs of CVA on brain CT are acceptable.
* Absence of previous neurological deficit of any etiology affecting the brain, e.g., trauma, or spinal cord.
* Vigilant, i.e., without quantitative impairment of consciousness. Delirium may be present.
Exclusion Criteria:
* Native speaker of the Czech Republic. Czech must be the patient\'s mother tongue.
* Admission to the monitored bed of the neurological ICU with the possibility of initial examination within 24 hours of admission (not the onset of CVA).
* Anticipated length of hospitalization longer than five days.
* First clinical CVA in life. Subclinical signs of CVA on brain CT are acceptable.
* Absence of previous neurological deficit of any etiology affecting the brain, e.g., trauma, or spinal cord.
* Vigilant, i.e., without quantitative impairment of consciousness. Delirium may be present.
* Presence of a previous neurological deficit.
* Unfavorable prognosis upon admission.
* Discharge or anticipation of early discharge from the ICU before the follow-up examination after 5 days.
* Transient ischemic attack and conditions mimicking stroke.
* Resoluti…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
POBAV test
Timeframe: 1st day after a stroke, 5th day after a stroke
2
ALBA test
Timeframe: 1st day after a stroke, 5th day after a stroke